India Pesticides Ltd
India Pesticides Limited is one of the globally operating agro-chemical manufactures in India, since 1984. The company is the sole Indian manufacturer and among the top five manufacturers globally for several Technicals, such as Folpet, Thiocarbamate Herbicide, and several other products [1]
- Market Cap ₹ 1,505 Cr.
- Current Price ₹ 131
- High / Low ₹ 213 / 125
- Stock P/E 14.0
- Book Value ₹ 87.7
- Dividend Yield 0.57 %
- ROCE 16.6 %
- ROE 12.5 %
- Face Value ₹ 1.00
Pros
Cons
- The company has delivered a poor sales growth of 10.3% over past five years.
- Company has a low return on equity of 10.0% over last 3 years.
- Dividend payout has been low at 10.7% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE Commodities BSE 1000
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| 649 | 716 | 885 | 680 | 829 | 1,057 | 1,034 | |
| 466 | 502 | 688 | 594 | 709 | 884 | 870 | |
| Operating Profit | 183 | 214 | 197 | 87 | 120 | 174 | 164 |
| OPM % | 28% | 30% | 22% | 13% | 14% | 16% | 16% |
| 6 | 13 | 13 | 15 | 15 | 21 | 16 | |
| Interest | 3 | 7 | 7 | 4 | 5 | 7 | 8 |
| Depreciation | 6 | 9 | 11 | 15 | 18 | 21 | 22 |
| Profit before tax | 180 | 212 | 192 | 82 | 111 | 166 | 150 |
| Tax % | 25% | 25% | 25% | 27% | 26% | 28% | |
| 135 | 158 | 143 | 60 | 82 | 120 | 108 | |
| EPS in Rs | 12.03 | 13.72 | 12.44 | 5.22 | 7.14 | 10.40 | 9.34 |
| Dividend Payout % | 3% | 5% | 6% | 14% | 11% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | -6% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -16% |
| 3 Years: | -23% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 10% |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 11 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 378 | 626 | 762 | 813 | 887 | 998 |
| 30 | 23 | 13 | 26 | 60 | 110 | |
| 97 | 131 | 135 | 151 | 183 | 215 | |
| Total Liabilities | 517 | 792 | 921 | 1,001 | 1,142 | 1,336 |
| 124 | 174 | 248 | 279 | 328 | 388 | |
| CWIP | 12 | 44 | 27 | 58 | 58 | 68 |
| Investments | 9 | 17 | 12 | 12 | 15 | 19 |
| 372 | 557 | 633 | 651 | 741 | 861 | |
| Total Assets | 517 | 792 | 921 | 1,001 | 1,142 | 1,336 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 83 | 76 | 45 | 115 | 3 | 62 | |
| -83 | -133 | -24 | -120 | -20 | -83 | |
| -4 | 71 | -25 | 3 | 19 | -76 | |
| Net Cash Flow | -4 | 14 | -4 | -2 | 2 | -97 |
| Free Cash Flow | 41 | -6 | -30 | 38 | -61 | -30 |
| CFO/OP | 70% | 61% | 47% | 157% | 22% | 59% |
Ratios
Consolidated / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 120 | 126 | 108 | 128 | 152 | 124 |
| Inventory Days | 88 | 163 | 175 | 202 | 205 | 191 |
| Days Payable | 92 | 110 | 80 | 92 | 99 | 92 |
| Cash Conversion Cycle | 116 | 179 | 203 | 238 | 257 | 224 |
| Working Capital Days | 120 | 158 | 164 | 185 | 179 | 161 |
| ROCE % | 40% | 27% | 11% | 13% | 17% |
Insights
In beta| Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Formulations Installed Capacity MT |
|
||||||||
| Technicals Installed Capacity MT |
|||||||||
| Top 10 Customer Revenue Concentration % |
|||||||||
| Export Revenue Share % |
|||||||||
| Number of Exporting Countries Count |
|||||||||
| Capacity Utilization % |
|||||||||
Extracted by Screener AI
Documents
Announcements
- Closure of Trading Window
-
Announcement under Regulation 30 (LODR)-Credit Rating
- CARE reaffirmed India Pesticides’ ratings: CARE A+; Stable/CARE A1+ for ₹100 crore facilities on 18 September 2026.
-
Press Release Regarding Regulatory Approvals For Insecticide And Herbicide Products In International Markets
- Received UK technical equivalence for an insecticide and Argentina registration for a herbicide on 18 September 2026.
-
Intimation Regarding Approval Of The Insecticide And Herbicide
- Insecticide approved in UK and herbicide registered in Argentina on 15 Sep 2026.
-
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - ESG Rating.
- India Pesticides received CRISIL ESG Score of 57 for FY2026 disclosures.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
Concalls
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
May 2022PPT
-
Feb 2022Transcript PPT
-
Feb 2022PPT
-
Oct 2021PPT
-
Jul 2021Transcript PPT
Leading Pesticides company[1]
India Pesticides is an R&D-driven chemical manufacturer of agrochemical technical, APIs, and formulation business.